We are live on ! Find out more
NLVP

New Leaf Venture Partners Portfolio holdings

AUM $43M
1-Year Est. Return 25.55%
This Fund
S&P 500
This Quarter Est. Return
+7.11%
1 Year Est. Return
-25.55%
3 Year Est. Return
+17.13%
5 Year Est. Return
+114.46%
10 Year Est. Return
+1,011.57%
AUM
$373M
AUM Growth
+$8.14M
Cap. Flow
+$4.89M
Cap. Flow %
1.31%
Top 10 Hldgs %
90.91%
Holding
22
New
2
Increased
1
Reduced
–
Closed
1

Top Buys

Rank Stock Value
1
XFOR icon
X4 Pharmaceuticals
XFOR
+$4.83M
2
PDSB icon
PDS Biotechnology
PDSB
+$767K
3
NERV icon
Minerva Neurosciences
NERV
+$164K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DCPH
1
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$92.5M 24.81%
4,104,140
– –
PRNB
2
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
$87.1M 23.36%
2,625,713
– –
ARVN icon
3
Arvinas
ARVN
$524M
$50.2M 13.46%
2,283,048
– –
HARP
4
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$38M 10.18%
292,141
– –
STIM icon
5
Neuronetics
STIM
$125M
$19.3M 5.17%
1,543,115
– –
ALEC icon
6
Alector
ALEC
$167M
$15M 4.01%
787,769
– –
APTX
7
DELISTED
Aptinyx Inc. Common Stock
APTX
$11M 2.95%
3,290,079
– –
OBSV
8
DELISTED
ObsEva SA Ordinary Shares
OBSV
$10.2M 2.73%
900,501
– –
ITRM
9
DELISTED
Iterum Therapeutics
ITRM
$10M 2.69%
97,087
– –
CMRX
10
DELISTED
Chimerix, Inc.
CMRX
$5.83M 1.56%
1,350,000
– –
ARAV
11
DELISTED
Aravive, Inc. Common Stock
ARAV
$5.82M 1.56%
970,659
– –
COGT icon
12
Cogent Biosciences
COGT
$6.83B
$4.7M 1.26%
448,886
– –
XFOR icon
13
X4 Pharmaceuticals
XFOR
$365M
$4.28M 1.15%
+9,500
New +$4.83M
CRNX icon
14
Crinetics Pharmaceuticals
CRNX
$8.86B
$4.19M 1.12%
167,700
– –
TECX
15
Tectonic Therapeutic
TECX
$581M
$3.5M 0.94%
17,963
– –
CHMA
16
DELISTED
Chiasma, Inc. Common Stock
CHMA
$2.99M 0.8%
400,000
– –
SRRA
17
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$2.81M 0.75%
125,511
– –
NERV icon
18
Minerva Neurosciences
NERV
$200M
$2.53M 0.68%
56,188
+3,275
+6% +$164K
AFMD
19
DELISTED
Affimed
AFMD
$2.1M 0.56%
73,277
– –
PDSB icon
20
PDS Biotechnology
PDSB
$38.7M
$702K 0.19%
+117,242
New +$767K
AVEO
21
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$271K 0.07%
40,212
– –

Similar funds

BAM
Broadcrest Asset Management Winter Park, Florida $44.1M AUM 4.51% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
WCPI
Wynnchurch Capital Partners IV Rosemont, Illinois $44.8M AUM 11.91% 1-Year Est. Return
WAMC
Western Asset Management Company Pasadena, California $45.2M AUM 6.96% 1-Year Est. Return
CC
Corton Capital Carrying Place, Ontario, Canada $40.7M AUM 52.32% 1-Year Est. Return
CIEP
Constellation Investimentos e Participacoes Sao Paulo, Brazil $46.7M AUM 23.3% 1-Year Est. Return
IPI
Inflection Point Investments London, United Kingdom $46.9M AUM 18.35% 1-Year Est. Return
VSAM
Value Star Asset Management Hong Kong $49.2M AUM 60.1% 1-Year Est. Return

New Leaf Venture Partners's Q2 2019 Portfolio in Review

As of Q2 2019, New Leaf Venture Partners held 22 positions worth $373M, up 2.2% from $365M the previous quarter. Its ten largest holdings account for 91% of the portfolio.

New Leaf Venture Partners's Q2 2019 filing shows 2 new, 1 increased and 1 closed positions. Its largest new stake was X4 Pharmaceuticals: 9,500 shares worth $4.28M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 100% a quarter earlier.

  • New Leaf Venture Partners's largest Q2 2019 buy was X4 Pharmaceuticals: 9,500 shares worth $4.28M.
  • New Leaf Venture Partners added most to Minerva Neurosciences in Q2 2019, an estimated $164K increase.
  • New Leaf Venture Partners's ten largest holdings make up 91% of its $373M portfolio in Q2 2019.
  • New Leaf Venture Partners opened 2 new positions and closed 1 in Q2 2019.
  • New Leaf Venture Partners's portfolio value rose 2.2% quarter-over-quarter to $373M.

Based on New Leaf Venture Partners's 13F filing for Q2 2019, filed 13 Aug 2019.